|
|
||||||||
Clinical Chemistry, Vol 38, 530-533, Copyright © 1992 by American Association for Clinical Chemistry
E MacDonald, WK Lee, S Hepburn, J Bell, PJ Scott and MH Dominiczak
Department of Biochemistry, Western Infirmary, Glasgow, Scotland, U.K.
We measured advanced glycosylation end products in the mesenteric artery of 37 patients (ages 29-82 years), 34 of whom were nondiabetic. Samples of arterial tissue were obtained during bowel resectioning. Advanced glycosylation end products were measured as collagen-linked fluorescence (excitation wavelength 370 nm, emission wavelength 440 nm) after collagenase digestion of tissue samples. Mean fluorescence of the arterial samples was 15 U/mg (range 5.3-27). Collagen fluorescence correlated with patients' age (r = 0.57; P less than 0.001). No difference in the collagen-linked fluorescence was observed between men and women (P = 0.63), hypertensive and normotensive patients (P = 0.44), smokers and nonsmokers (P = -0.52), and patients with and without symptomatic coronary heart disease (P = 0.7). This study demonstrates, for the first time, the relationship between collagen- linked fluorescence and patients' age in human arterial tissue ex vivo.
The following articles in journals at HighWire Press have cited this article:
![]() |
B. H. R. Wolffenbuttel, C. M. Boulanger, F. R. L. Crijns, M. S. P. Huijberts, P. Poitevin, G. N. M. Swennen, S. Vasan, J. J. Egan, P. Ulrich, A. Cerami, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes PNAS, April 14, 1998; 95(8): 4630 - 4634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |